Literature DB >> 30863908

Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models.

Laurent Coudert1, Takashi Nonaka2, Emilien Bernard3,4, Masato Hasegawa2, Laurent Schaeffer1, Pascal Leblanc5.   

Abstract

The Tar DNA-Binding Protein 43 (TDP-43) and its phosphorylated isoform (pTDP-43) are the major components associated with ubiquitin positive/Tau-negative inclusions found in neurons and glial cells of patients suffering of amyotrophic lateral sclerosis (ALS) or frontotemporal lobar degeneration-TDP-43 (FTLD-TDP). Many studies have revealed that TDP-43 is also in the protein inclusions associated with neurodegenerative conditions other than ALS and FTLD-TDP, thus suggesting that this protein may be involved in the pathogenesis of a variety of neurological disorders. In brains of Huntington-affected patients, pTDP-43 aggregates were shown to co-localize with mutant Huntingtin (mHtt) inclusions. Here, we show that expression of mHtt carrying 80-97 polyglutamines repeats in human cell cultures induces the aggregation and the phosphorylation of endogenous TDP-43, whereas non-pathological Htt with 25 polyglutamines repeats has no effect. Mutant Htt aggregation precedes accumulation of pTDP-43 and pTDP-43 co-localizes with mHtt inclusions reminding what it was previously described in brains of Huntington-affected patients. Detergent-insoluble fractions from cells expressing mHtt and containing mHtt-pTDP-43 co-aggregates can function as seeds for further TDP-43 aggregation in human cell culture. The human cellular prion protein PrPC was previously identified as a negative modulator of mHtt aggregation; here, we show that PrPC-mediated reduction of mHtt aggregation is tightly correlated with a decrease of TDP-43 aggregation and phosphorylation, thus confirming the close relationships between TDP-43 and mHtt.

Entities:  

Keywords:  ALS; Huntingtin; Huntington; Phosphorylation; Prion; Seeds; TDP-43

Mesh:

Substances:

Year:  2019        PMID: 30863908     DOI: 10.1007/s00018-019-03059-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  69 in total

1.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.

Authors:  Montserrat Arrasate; Siddhartha Mitra; Erik S Schweitzer; Mark R Segal; Steven Finkbeiner
Journal:  Nature       Date:  2004-10-14       Impact factor: 49.962

2.  TDP-43 is deposited in the Guam parkinsonism-dementia complex brains.

Authors:  Masato Hasegawa; Tetsuaki Arai; Haruhiko Akiyama; Takashi Nonaka; Hiroshi Mori; Tomoyo Hashimoto; Mineo Yamazaki; Kiyomitsu Oyanagi
Journal:  Brain       Date:  2007-04-17       Impact factor: 13.501

3.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.

Authors:  E Scherzinger; A Sittler; K Schweiger; V Heiser; R Lurz; R Hasenbank; G P Bates; H Lehrach; E E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

4.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

Review 5.  Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease.

Authors:  J F Gusella; M E MacDonald
Journal:  Nat Rev Neurosci       Date:  2000-11       Impact factor: 34.870

6.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

7.  Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.

Authors:  Irina L Derkatch; Susan M Uptain; Tiago F Outeiro; Rajaraman Krishnan; Susan L Lindquist; Susan W Liebman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

8.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

9.  Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

Authors:  Hanae Nakashima-Yasuda; Kunihiro Uryu; John Robinson; Sharon X Xie; Howard Hurtig; John E Duda; Steven E Arnold; Andrew Siderowf; Murray Grossman; James B Leverenz; Randy Woltjer; Oscar L Lopez; Ronald Hamilton; Debby W Tsuang; Douglas Galasko; Eliezer Masliah; Jeffrey Kaye; Christopher M Clark; Thomas J Montine; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2007-07-25       Impact factor: 17.088

10.  Cellular prion protein (PrPC) protects neuronal cells from the effect of huntingtin aggregation.

Authors:  Kyung-Jin Lee; Antony Panzera; David Rogawski; Lois E Greene; Evan Eisenberg
Journal:  J Cell Sci       Date:  2007-07-17       Impact factor: 5.285

View more
  7 in total

Review 1.  The Role of TDP-43 in Neurodegenerative Disease.

Authors:  Yan-Zhe Liao; Jing Ma; Jie-Zhi Dou
Journal:  Mol Neurobiol       Date:  2022-05-02       Impact factor: 5.590

Review 2.  Proteostasis Perturbations and Their Roles in Causing Sterile Inflammation and Autoinflammatory Diseases.

Authors:  Jonas Johannes Papendorf; Elke Krüger; Frédéric Ebstein
Journal:  Cells       Date:  2022-04-22       Impact factor: 7.666

Review 3.  Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington's Disease.

Authors:  Marta Fernández-Nogales; José J Lucas
Journal:  Front Cell Neurosci       Date:  2020-01-17       Impact factor: 5.505

Review 4.  Looking at the Pretty "Phase" of Membraneless Organelles: A View From Drosophila Glia.

Authors:  Alexey L Arkov
Journal:  Front Cell Dev Biol       Date:  2022-02-07

5.  Key Modulators of the Stress Granule Response TIA1, TDP-43, and G3BP1 Are Altered by Polyglutamine-Expanded ATXN7.

Authors:  Frida Niss; Laura Piñero-Paez; Wajiha Zaidi; Einar Hallberg; Anna-Lena Ström
Journal:  Mol Neurobiol       Date:  2022-06-10       Impact factor: 5.682

Review 6.  Hunting for the cause: Evidence for prion-like mechanisms in Huntington's disease.

Authors:  Kirby M Donnelly; Cevannah M Coleman; Madison L Fuller; Victoria L Reed; Dayna Smerina; David S Tomlinson; Margaret M Panning Pearce
Journal:  Front Neurosci       Date:  2022-08-24       Impact factor: 5.152

Review 7.  The Integral Role of RNA in Stress Granule Formation and Function.

Authors:  Danae Campos-Melo; Zachary C E Hawley; Cristian A Droppelmann; Michael J Strong
Journal:  Front Cell Dev Biol       Date:  2021-05-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.